DrugPatentWatch Database Preview
Drugs in Development Information for Magnesium gluconate
» See Plans and Pricing
What is the drug development status for Magnesium gluconate?
Magnesium gluconate is an investigational drug.
There have been 10 clinical trials for Magnesium gluconate.
The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2020.
The most common disease conditions in clinical trials are Neurotoxicity Syndromes, Colorectal Neoplasms, and Peripheral Nervous System Diseases. The leading clinical trial sponsors are National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, and University of Alberta.
There are seven hundred and forty-nine US patents protecting this investigational drug and five international patents.
Summary for Magnesium gluconate
| US Patents | 749 |
| International Patents | 5,255 |
| US Patent Applications | 1,349 |
| WIPO Patent Applications | 804 |
| Japanese Patent Applications | 2 |
| Clinical Trial Progress | Phase 3 (2020-07-01) |
| Vendors | 27 |
Recent Clinical Trials for Magnesium gluconate
| Title | Sponsor | Phase |
|---|---|---|
| The Effect of Preoperative Oral Dexamethasone Supplementation on the Outcome of Thyroidectomised Patients. | Medical Universtity of Lodz | Phase 4 |
| Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA | Woman's | Phase 4 |
| Low Dose Magnesium Sulphate Versus Standard Pritchard Regimen In Management Of Severe Preeclampsia/Eclampsia | Adebayo Joshua Adeniyi | N/A |
Clinical Trial Summary for Magnesium gluconate
Top disease conditions for Magnesium gluconate
Top clinical trial sponsors for Magnesium gluconate
US Patents for Magnesium gluconate
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Magnesium gluconate | Start Trial | Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome | ANTECIP BIOVENTURES II LLC (New York, NY) | Start Trial |
| Magnesium gluconate | Start Trial | Dialysis formulation | GAMBRO LUNDIA AB (Lund, SE) | Start Trial |
| Magnesium gluconate | Start Trial | Prevention of micronutrient deficiencies associated with common disabilities in the over 50 adult | Start Trial | |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Magnesium gluconate
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Magnesium gluconate | Australia | AU2013262995 | 2032-05-14 | Start Trial |
| Magnesium gluconate | Australia | AU2014340649 | 2032-05-14 | Start Trial |
| Magnesium gluconate | Australia | AU2015267046 | 2032-05-14 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
